Source:http://linkedlifedata.com/resource/pubmed/id/16755142
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005823,
umls-concept:C0030705,
umls-concept:C0085580,
umls-concept:C0149721,
umls-concept:C0165703,
umls-concept:C0205314,
umls-concept:C0220825,
umls-concept:C0225897,
umls-concept:C0443252,
umls-concept:C0679622,
umls-concept:C1522602,
umls-concept:C1555029,
umls-concept:C2003888,
umls-concept:C2828008
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-6-9
|
pubmed:abstractText |
Left ventricular hypertrophy is an independent risk factor for cardiovascular disease. We evaluated the effect of long-term and strict antihypertensive therapy with and without the angiotensin-converting enzyme inhibitor (ACEI) imidapril on left ventricular hypertrophy using a novel indicator of chronic burden on the left ventricle, the area under the blood pressure curve x the duration of high blood pressure (AUSBP and AUDBP), in patients with essential hypertension. The patients were divided into 2 groups: an ACEI group, in which imidapril was used in addition to antihypertensive drugs such as Ca channel blockers, beta-blockers, diuretics or angiotensin II antagonist; and a non-ACEI group, in which Ca channel blockers and diuretics were used. Systolic and diastolic blood pressures (SBP and DBP) were both maintained at below 140 and 90 mmHg, respectively, for 2 years. There was no significant difference in the left ventricular mass (LVM) assessed by echocardiography at baseline and that at 2 years of follow-up in the non-ACEI group. However, the LVM in the ACEI group was significantly decreased at 2 years of follow-up as compared to that at the baseline visit. There was no difference in the mean AUSBP and AUDBP between the ACEI and non-ACEI groups. Changes in the LVM were not correlated with the AUSBP or AUDBP in both the ACEI and non-ACEI groups. These findings suggest that the decrease in the LVM in the ACEI group was mediated through mechanisms other than the blood pressure lowering-effect and that AUSBP and AUDBP may be novel indicators of the long-term burden on the left ventricle.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0916-9636
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
89-94
|
pubmed:meshHeading |
pubmed-meshheading:16755142-Aged,
pubmed-meshheading:16755142-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:16755142-Blood Pressure,
pubmed-meshheading:16755142-Female,
pubmed-meshheading:16755142-Heart Ventricles,
pubmed-meshheading:16755142-Humans,
pubmed-meshheading:16755142-Hypertension,
pubmed-meshheading:16755142-Hypertrophy, Left Ventricular,
pubmed-meshheading:16755142-Imidazolidines,
pubmed-meshheading:16755142-Male,
pubmed-meshheading:16755142-Middle Aged,
pubmed-meshheading:16755142-Prospective Studies,
pubmed-meshheading:16755142-Time Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Long-term and strict blood pressure lowering by imidapril reverses left ventricular hypertrophy in patients with essential hypertension: an evaluation using a novel indicator of burden on the left ventricle.
|
pubmed:affiliation |
Second Department of Internal Medicine, Gifu University School of Medicine, Yanagido 1-1, Gifu 501-1911, Japan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|